Amica Mutual Insurance Co. Invests $1.26 Million in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Amica Mutual Insurance Co. acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 14,127 shares of the exchange traded fund’s stock, valued at approximately $1,261,000.

A number of other institutional investors have also added to or reduced their stakes in the company. Avaii Wealth Management LLC raised its holdings in SPDR S&P Biotech ETF by 5.5% in the 4th quarter. Avaii Wealth Management LLC now owns 3,870 shares of the exchange traded fund’s stock valued at $346,000 after acquiring an additional 203 shares in the last quarter. McAdam LLC lifted its position in SPDR S&P Biotech ETF by 3.7% in the fourth quarter. McAdam LLC now owns 8,212 shares of the exchange traded fund’s stock worth $733,000 after purchasing an additional 295 shares during the period. Eagle Wealth Strategies LLC acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter worth $470,000. Conservest Capital Advisors Inc. increased its holdings in SPDR S&P Biotech ETF by 2.4% in the 4th quarter. Conservest Capital Advisors Inc. now owns 38,991 shares of the exchange traded fund’s stock valued at $3,482,000 after buying an additional 912 shares during the period. Finally, Pursue Wealth Partners LLC raised its stake in shares of SPDR S&P Biotech ETF by 17.5% in the 4th quarter. Pursue Wealth Partners LLC now owns 13,846 shares of the exchange traded fund’s stock valued at $1,236,000 after buying an additional 2,060 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI traded up $2.11 during midday trading on Monday, reaching $85.60. 10,491,644 shares of the company’s stock were exchanged, compared to its average volume of 11,708,974. The company’s 50 day simple moving average is $92.54 and its two-hundred day simple moving average is $84.94. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52. The firm has a market capitalization of $6.65 billion, a PE ratio of 11.47 and a beta of 1.08.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.